Trans-NIH Research Support in Massachusetts
Trans-NIH Research Support (93.310) awarded $571 million to recipients in Massachusetts in 395 grants from fiscal 2021 to 2025, 9.7% of the program's national total. The General Hospital Corporation received the most, $145 million.
- Awarded in Massachusetts$571 million
- Awards395
- Share of the program9.7%
- Rank among states2nd of 54
- National total$5.9 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 136 | $120 million |
| FY 2022 | 119 | $110 million |
| FY 2023 | 150 | $116 million |
| FY 2024 | 134 | $116 million |
| FY 2025 | 126 | $109 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Nonprofits | 58 | $145 million |
| The Broad Institute, Inc | Nonprofits | 28 | $79.3 million |
| Brigham & Womens Hospital Inc | Nonprofits | 45 | $53.0 million |
| President and Fellows of Harvard College | Colleges and universities | 19 | $43.4 million |
| University of Massachusetts Medical School | Colleges and universities | 23 | $33.6 million |
| The Children's Hospital Corporation | Nonprofits | 29 | $28.9 million |
| Northeastern University | Colleges and universities | 9 | $21.7 million |
| Massachusetts Institute of Technology | Colleges and universities | 16 | $20.9 million |
| President and Fellows of Harvard College | Colleges and universities | 15 | $18.1 million |
| Beth Israel Deaconess Medical Center, Inc. | Nonprofits | 16 | $16.5 million |
Open opportunities under this program
- Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
See all 95 on the program page
Questions people ask
How much Trans-NIH Research Support money goes to Massachusetts?
$571 million from fiscal 2021 to 2025, across 395 awards. Massachusetts ranks 2nd of 54 states and territories for this program.
Who receives Trans-NIH Research Support money in Massachusetts?
The largest recipient is The General Hospital Corporation, with $145 million in 58 awards. Next are The Broad Institute, Inc and Brigham & Womens Hospital Inc.
Can organizations in Massachusetts apply now?
Yes, 95 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Trans-NIH Research Support in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research